LALPATHLAB.NS Balance Sheet
Dr. Lal Path Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹401.00 Cr. | ₹343.00 Cr. | ₹335.80 Cr. | ₹483.80 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹3.00 Cr. | ₹4.00 Cr. | ₹3.50 Cr. | ₹5.50 Cr. | CapitalWorkInProgress |
| Goodwill | ₹547.80 Cr. | ₹548.20 Cr. | ₹548.10 Cr. | ₹548.20 Cr. | Goodwill |
| Other Intangible Assets | ₹356.20 Cr. | ₹302.60 Cr. | ₹251.10 Cr. | ₹191.50 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹21.90 Cr. | ₹19.50 Cr. | ₹13.60 Cr. | ₹19.70 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹1,412.50 Cr. | ₹1,329.30 Cr. | ₹1,353.30 Cr. | ₹1,579.40 Cr. | NoncurrentAssets |
| Inventories | ₹33.80 Cr. | ₹37.30 Cr. | ₹36.10 Cr. | ₹43.90 Cr. | Inventories |
| Trade Receivables | ₹70.80 Cr. | ₹77.40 Cr. | ₹88.10 Cr. | ₹110.70 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹263.70 Cr. | ₹360.90 Cr. | ₹292.60 Cr. | ₹242.80 Cr. | CashAndCashEquivalents |
| Current Investments | ₹149.90 Cr. | ₹113.80 Cr. | ₹326.70 Cr. | ₹422.60 Cr. | CurrentInvestments |
| Other Current Assets | ₹16.00 Cr. | ₹19.60 Cr. | ₹22.40 Cr. | ₹22.30 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹973.00 Cr. | ₹1,126.70 Cr. | ₹1,363.50 Cr. | ₹1,566.60 Cr. | CurrentAssets |
| Total Assets | ₹2,385.50 Cr. | ₹2,456.00 Cr. | ₹2,716.80 Cr. | ₹3,146.00 Cr. | Assets |
| Equity Share Capital | ₹83.40 Cr. | ₹83.50 Cr. | ₹83.60 Cr. | ₹167.60 Cr. | EquityShareCapital |
| Other Equity | ₹1,582.90 Cr. | ₹1,765.80 Cr. | ₹2,089.10 Cr. | ₹2,340.60 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹1,666.30 Cr. | ₹1,849.30 Cr. | ₹2,172.70 Cr. | ₹2,508.20 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹33.20 Cr. | ₹36.10 Cr. | ₹33.80 Cr. | ₹33.10 Cr. | NonControllingInterest |
| Total Equity | ₹1,699.50 Cr. | ₹1,885.40 Cr. | ₹2,206.50 Cr. | ₹2,541.30 Cr. | Equity |
| Long-term Borrowings | ₹83.30 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹216.20 Cr. | ₹105.40 Cr. | ₹107.80 Cr. | ₹154.00 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹153.30 Cr. | ₹83.30 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsCurrent |
| Trade Payables | ₹156.10 Cr. | ₹186.60 Cr. | ₹198.80 Cr. | ₹180.60 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹31.60 Cr. | ₹34.80 Cr. | ₹43.10 Cr. | ₹42.00 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹469.80 Cr. | ₹465.20 Cr. | ₹402.50 Cr. | ₹450.70 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹2,385.50 Cr. | ₹2,456.00 Cr. | ₹2,716.80 Cr. | ₹3,146.00 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from LALPATHLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).